Usefulness of skin testing in cutaneous drug eruptions in routine practice

Contact Dermatitis

Volumn 61, Issue 3, 2009, Pages 138-144

  Tchen, Tatiana ^a   Reguiaï, Zïad ^a   Vitry, Fabien ^b   Arnoult, Elizabeth ^a   Grange, Anne ^a   Florent, Grange ^a   Bernard, Phillipe ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Cutaneous drug eruption; Skin testing

Indexed keywords

ANESTHETIC AGENT; ANTIINFECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RASH; SCHOOL CHILD; SCORING SYSTEM; SKIN MANIFESTATION; SKIN TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; EXANTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN DISEASES, PAPULOSQUAMOUS; SKIN TESTS; URTICARIA; YOUNG ADULT;

EID: 70349541102     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2009.01578.x     Document Type: Article

References (35)

1. Bachot N, Roujeau J C. Imputabilité médicamenteuse en pratique dermatologique quotidienne. Ann Dermatol Venereol 2000 : 127 : 542 547.
2. Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F, Royer R J. Adverse drug reaction monitoring: doing it the French way. Lancet 1985 : ii : 1056 1058.
3. Barbaud A, Reichert-Penetrat S, Trechot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998 : 139 : 49 58. (Pubitemid 28338063)
4. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001 : 45 : 321 328. (Pubitemid 34056345)
5. Adams R M, Fischer T. Diagnostic patch testing. In: Occupational Skin Diseases, Adams R M (ed.): 2nd edition. Philadelphia, WB Saunders Co., 1990 : 223 253.
6. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005 : 152 : 968 974.
7. Wöhrl S, Vigl K, Stingl G. Patients with drug reactions -is it worth testing? Allergy 2006 : 61 : 928 934.
8. Choquet-Kastylevsky G, Vial T, Santolaria N, Nageotte A, Claudy A, Descotes J. Cutaneous adverse drug reactions: enhanced imputability scores by skin testing. Ann Dermatol Venereol 2001 : 128 : 507 511.
9. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005 : 209 : 209 219.
10. Barbaud A. Usefulness of drug patch testing in cutaneous drug allergy: what is new? Rev Fr Allergol Immunol Clin 2003 : 43 : 222 226.
11. Roujeau J C, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991 : 127 : 1333 1338.
12. Barbaud A, Bene M C, Faure G, Schmutz J L. Tests cutanés dans l'exploration des toxidermies supposées de mécanisme immuno-allergique. Bull Acad Natl Med 2000 : 184 : 47 63.
13. Osawa J, Naito S, Aihara M, Kitamura K, Nakajima H. Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 1990 : 17 : 235 239.
14. Bruynzeel D P, Van Ketel W G. Skin tests in the diagnosis of maculopapular drug eruptions. Sem Dermatol 1987 : 6 : 119 124.
15. Wolkenstein P, Chosidow O, Flechet M L, Robbiola O, Paul M, Dume L, Revuz J, Roujeau J C. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996 : 35 : 234 236. (Pubitemid 26408155)
16. Hunziker T, Kunzi U P, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997 : 2 : 388 393.
17. Gruchalla R S, Pirmohamed M. Antibiotic allergy. N Engl J Med 2006 : 354 : 601 609.
18. Ponvert C, Le Clainche L, de Blic J, Le Bourgeois M, Scheinmann P, Paupe J. Allergy to beta-lactam antibiotics in children. Pediatrics 1999 : 104 : e45.
19. Romano A, Di Fonso M, Pietrantonio F, Pocobelli D, Giannarini L, Del Bono A, Fabrizi G, Venuti A. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics. Contact Dermatitis 1993 : 28 : 190.
20. Romano A, Viola M, Mondino C, Pettinato R, Di Fonso M, Papa G, Venuti A, Montuschi P. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002 : 129 : 169 174.
21. Klein C E, Trautmann A, Zillikens D, Brocker E B. Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis 1995 : 33 : 448 449.
22. Barbaud A, Trechot P, Weber-Muller F, Ulrich G, Commun N, Schmutz J L. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Dermatitis 2004 : 50 : 22 26.
23. Bernedo N, Gonzalez I, Gastaminza G, Audicana M, Fernandez E, Munoz D. Positive patch tests in vancomycin allergy. Contact Dermatitis 2001 : 45 : 43.
24. Lammintausta K, Mäkella L, Kalimo K. Rapid systemic valaciclovir reaction subsequent to aciclovir contact allergy. Contact Dermatitis 2001 : 45 : 181.
25. Vernassière C, Barbaud A, Trechot P, Weber-Muller F, Schmutz J L. Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used? Contact Dermatitis 2003 : 49 : 155 157.
26. Rodriguez-Morales A, Alonso Llamazares A, Palacios Benito R, Martinez Cocera C. Fixed drug eruption from quinolones with positive lesional patch test to ciprofloxacin. Contact Dermatitis 2001 : 44 : 255.
27. Figarella I, Barbaud A, Lecompte T, De Maistre E, Reichert-Penetrat S, Schmutz J L. Cutaneous delayed hypersensitivity reactions to heparins and heparinoids. Ann Dermatol Venereol 2001 : 128 : 25 30.
28. Frouin E, Roth B, Grange A, Grange F, Tortel M C, Guillaume J C. Hypersensitivity to fluindione (Previscan). Positive skin patch tests. Ann Dermatol Venereol 2005 : 132 : 1000 1002.
29. Romano A, Pietrantonio F, Di Fonso M, Rumi C, Belloci F, Caradonna P, Barone C. Delayed hypersensitivity to diltiazem in two patients. Ann Allergy 1992 : 69 : 31 32.
30. Veyrac G, Jolliet P. Urticaire mèdicamenteuse et imputabilitè. Revue francaise d'allergologie et d'immunologie clinique 2006 : 43 : 283 287.
31. Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt D J, Pirmohamed M, Park B K, Pichler W J. Recognition of sulfamethoxazole and its metabolites by drug-specific CD4+ cells from allergic individuals. J Immunol 2000 : 164 : 6647 6654.
32. Roujeau J C. Immune mechanisms in drug allergy. Allergol Int 2006 : 55 : 27 33.
33. Pichler W, Yawalkar N, Schmid S, Helbling A. Pathogenesis of drug-induced exanthems. Allergy 2002 : 57 : 884 893.
34. Lammintausta K, Kortekangas-Savolainon O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol 2005 : 85 : 491 496.
35. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004 : 140 : 1001 1006.